東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

HIV-1 Tat Activates ERK1/2 Signaling...

Yeakle, Kyle Christopher,

FindBook

Google Book

Amazon

博客來

HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival // Kyle Christopher Yeakle.
作者:	Yeakle, Kyle Christopher,
面頁冊數:	1 electronic resource (121 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-07, Section: B.
Contained By:	Dissertations Abstracts International86-07B.
標題:	Virology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31770575
ISBN:	9798302830067

HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival /
Yeakle, Kyle Christopher,

HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival /Kyle Christopher Yeakle. - 1 electronic resource (121 pages)

Source: Dissertations Abstracts International, Volume: 86-07, Section: B.

Globally, a chronic hepatitis B virus (HBV) infection is the leading cause of hepatocellular carcinoma (HCC). The increased risk of HCC persists in patients treated with antiviral therapy, despite suppressing viral replication. Co-infection with human immunodeficiency virus (HIV) increases the risk of developing HCC by 18-fold relative to an HBV mono-infection. Despite the clear clinical burden posed by an HIV/HBV co-infection, the mechanisms underlying the increased risk of HCC are understudied due to a lack of relevant model systems. We developed an in vitro model of HIV/HBV co-infection using Jurkat cells with inducible expression of HIV-1 Tat co-cultured with HBV-infected primary rat hepatocytes. The co-culture model was used to investigate the effect of HIV-1 Tat on HBV replication and cell survival in HBV-infected hepatocytes. Results from Jurkat-secreted Tat were complemented with purified HIV-1 Tat to determine the effect of Tat alone. Exposure to Tat significantly upregulated ERK1/2 and NF-κB signaling and cell survival in HBV-infected and uninfected hepatocytes. The activation of ERK1/2 and NF-κB signaling by Tat also inhibited HBV replication, which could be rescued by inhibition of ERK1/2 with temuterkib. Tat-dependent activation of NF-κB signaling and cell survival was also reversed by treatment with temuterkib. Tat-mediated activation of NF-κB signaling and cell survival is initiated by the TLR-4 cell surface receptor and recruitment of PKC-delta to the plasma membrane. Overall, the results of these studies indicate that Tat-mediated upregulation of ERK1/2 may promote oncogenesis and contribute to the development of HCC during an HIV/HBV co-infection by promoting cell survival.

English

ISBN: 9798302830067Subjects--Topical Terms:

642304
Virology.
Subjects--Index Terms:

Co-infection

HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival /
LDR:03164nmm a22004093i 4500 001 2437552
005 20251124054803.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798302830067
035 $a (MiAaPQD)AAI31770575
035 $a AAI31770575
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Yeakle, Kyle Christopher, $e author. $0 (orcid)0000-0001-9112-8656 $3 3828577
245 1 0 $a HIV-1 Tat Activates ERK1/2 Signaling in HBV-Infected Hepatocytes to Inhibit HBV Replication and Promote Hepatocyte Survival / $c Kyle Christopher Yeakle.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (121 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-07, Section: B.
500 $a Advisors: Reginato, Mauricio Committee members: Nonnemacher, Mike; Bouchard, Michael; Thio, Chloe; Noh, Moses.
502 $b Ph.D. $c Drexel University $d 2025.
520 $a Globally, a chronic hepatitis B virus (HBV) infection is the leading cause of hepatocellular carcinoma (HCC). The increased risk of HCC persists in patients treated with antiviral therapy, despite suppressing viral replication. Co-infection with human immunodeficiency virus (HIV) increases the risk of developing HCC by 18-fold relative to an HBV mono-infection. Despite the clear clinical burden posed by an HIV/HBV co-infection, the mechanisms underlying the increased risk of HCC are understudied due to a lack of relevant model systems. We developed an in vitro model of HIV/HBV co-infection using Jurkat cells with inducible expression of HIV-1 Tat co-cultured with HBV-infected primary rat hepatocytes. The co-culture model was used to investigate the effect of HIV-1 Tat on HBV replication and cell survival in HBV-infected hepatocytes. Results from Jurkat-secreted Tat were complemented with purified HIV-1 Tat to determine the effect of Tat alone. Exposure to Tat significantly upregulated ERK1/2 and NF-κB signaling and cell survival in HBV-infected and uninfected hepatocytes. The activation of ERK1/2 and NF-κB signaling by Tat also inhibited HBV replication, which could be rescued by inhibition of ERK1/2 with temuterkib. Tat-dependent activation of NF-κB signaling and cell survival was also reversed by treatment with temuterkib. Tat-mediated activation of NF-κB signaling and cell survival is initiated by the TLR-4 cell surface receptor and recruitment of PKC-delta to the plasma membrane. Overall, the results of these studies indicate that Tat-mediated upregulation of ERK1/2 may promote oncogenesis and contribute to the development of HCC during an HIV/HBV co-infection by promoting cell survival.
546 $a English
590 $a School code: 0065
650 4 $a Virology. $3 642304
650 4 $a Cellular biology. $3 3172791
650 4 $a Physiology. $3 518431
653 $a Co-infection
653 $a Hepatocyte
653 $a Hepatitis B virus
690 $a 0720
690 $a 0379
690 $a 0719
710 2 $a Drexel University. $b Biochemistry (College of Medicine). $e degree granting institution. $3 3828578
720 1 $a Reginato, Mauricio $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-07B.
790 $a 0065
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31770575